Skip to main content
UniHealth

Doctor search

Hiroyu Hatano, MD

Internal Medicine · Palo Alto

NPI 1871631507

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
Not verified
Not the same as out of network.
Office
1

Offices

1 location

Plan participation

Not verified

We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Hatano’s office at (650) 850-4111 to ask if they take your plan before you enroll.

California Medical Board record

Licence A87614 · Current

Licensed to practise in California · since 2004 · expires 2028-04-30 · Stanford University School of Medicine.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

School, training and certification

What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.

Specialty certification

  • American Board of Internal Medicine - Internal Medicine

Drugs they prescribed that Part D paid

$38,973

Pharmacies billed $38,973 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

325 generic and 102 brand-name prescriptions · $38,973 in drug cost · 19 antibiotic prescriptions to 12 people.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Mounjaro14$14,778$1,056
Motegrity12$6,063$505
Synthroid28$2,915$104
Lubiprostone12$1,083$90
Rosuvastatin19$492$26
See all 13 drugs
Every Part D drug this clinician prescribed
Mounjaro14$14,778$1,056
Motegrity12$6,063$505
Synthroid28$2,915$104
Lubiprostone12$1,083$90
Rosuvastatin19$492$26
Losartan26$428$16
Atorvastatin24$365$15
Gabapentin29$332$11
Escitalopram17$266$16
Amlodipine Besylate20$243$12
Levothyroxine17$185$11
Azithromycin11$68$6
Lorazepam23$62$3

Year by year

Part D prescribing by year
202442726None24%$38,973
202340424NoneNone$29,927
2022451275% (24)27%$52,829
2021456296% (29)26%$50,442
2020537312% (13)21%$48,780
2019489324% (20)19%$36,285
2018535325% (25)19%$35,376
2017421306% (24)20%$23,485
2016434335% (23)30%$78,889
2015620202% (12)50%$337,573
2014682203% (23)48%$337,284
2013635153% (21)51%$320,940

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 12 drugs

Part D drugs prescribed in 2023
Motegrity12$5,800$483
Livalo12$4,080$340
Synthroid28$3,746$134
Lubiprostone13$2,995$230
Atorvastatin25$414$17
Rosuvastatin19$299$16
Amlodipine Besylate22$289$13
Escitalopram11$199$18
Losartan20$170$8
Gabapentin25$157$6
Levothyroxine16$138$9
Lorazepam19$44$2

2022: 15 drugs

Part D drugs prescribed in 2022
Victoza 3-Pak12$13,749$1,146
Lubiprostone23$6,645$289
Motegrity12$5,587$466
Synthroid30$3,501$117
Amlodipine Besylate30$430$14
Losartan29$415$14
Atorvastatin28$387$14
Gabapentin26$370$14
Rosuvastatin16$231$14
Levothyroxine13$150$12
Paxlovid (Eua)13$140$11
Oxycodone12$103$9
Azithromycin12$96$8
Lorazepam20$30$1
Pravastatin11$25$2

2021: 12 drugs

Part D drugs prescribed in 2021
Livalo11$3,698$336
Lubiprostone12$3,474$290
Synthroid25$2,226$89
Amlodipine Besylate33$482$15
Atorvastatin22$412$19
Losartan21$377$18
Gabapentin25$373$15
Levothyroxine19$232$12
Oxycodone14$175$13
Rosuvastatin16$122$8
Zolpidem11$88$8
Lorazepam13$50$4

2020: 14 drugs

Part D drugs prescribed in 2020
Victoza 3-Pak13$12,771$982
Amitiza13$5,106$393
Synthroid26$2,073$80
Zolpidem12$823$69
Atorvastatin48$767$16
Diclofenac16$568$35
Gabapentin41$519$13
Levothyroxine23$448$19
Amlodipine Besylate30$381$13
Losartan21$324$15
Pregabalin13$313$24
Rosuvastatin16$248$15
Omeprazole12$182$15
Trazodone17$161$9

2019: 15 drugs

Part D drugs prescribed in 2019
Amitiza15$5,864$391
Synthroid17$1,052$62
Atorvastatin36$947$26
Hydrocodone-Acetaminophen17$771$45
Levothyroxine23$485$21
Gabapentin21$346$16
Trazodone12$307$26
Losartan18$299$17
Bupropion Xl13$280$22
Omeprazole23$275$12
Rosuvastatin15$265$18
Diclofenac15$264$18
Amlodipine Besylate22$258$12
Azithromycin16$132$8
Zolpidem19$105$6

2018: 15 drugs

Part D drugs prescribed in 2018
Lyrica11$5,252$477
Duloxetine12$1,095$91
Hydrocodone-Acetaminophen22$1,087$49
Atorvastatin40$1,080$27
Synthroid15$871$58
Levothyroxine27$624$23
Bupropion Xl18$580$32
Irbesartan12$532$44
Omeprazole21$367$17
Gabapentin21$295$14
Amlodipine Besylate23$260$11
Trazodone11$183$17
Zolpidem24$175$7
Azithromycin23$163$7
Losartan13$127$10

2017: 12 drugs

Part D drugs prescribed in 2017
Lyrica12$4,774$398
Duloxetine12$1,231$103
Synthroid27$1,208$45
Levothyroxine33$776$24
Atorvastatin31$518$17
Liothyronine11$485$44
Hydrocodone-Acetaminophen21$361$17
Omeprazole18$317$18
Trazodone11$169$15
Amlodipine Besylate13$99$8
Azithromycin11$78$7
Losartan11$46$4

2016: 9 drugs

Part D drugs prescribed in 2016
Synthroid24$1,154$48
Hydrocodone-Acetaminophen16$1,092$68
Atorvastatin28$588$21
Rabeprazole12$562$47
Levothyroxine18$425$24
Trazodone13$231$18
Diclofenac14$217$15
Amlodipine Besylate18$138$8
Hydrochlorothiazide12$53$4

2015: 29 drugs

Part D drugs prescribed in 2015
Atripla24$53,205$2,217
Truvada34$46,473$1,367
Reyataz29$36,567$1,261
Triumeq13$27,864$2,143
Epzicom25$27,578$1,103
Viread27$24,504$908
Isentress18$21,316$1,184
Prezista15$19,191$1,279
Kaletra13$10,411$801
Sustiva12$10,176$848
Norvir36$9,403$261
Lyrica11$4,094$372
Lamivudine12$3,869$322
Avodart11$1,596$145
Fluconazole11$1,412$128
Oxycodone11$605$55
Omega-3 Acid Ethyl Esters13$583$45
Gabapentin12$529$44
Pravastatin14$262$19
Acyclovir12$197$16
Terazosin31$184$6
Levothyroxine13$163$13
Pantoprazole12$112$9
Nortriptyline14$97$7
Atorvastatin11$87$8
Amlodipine Besylate21$82$4
Methimazole13$74$6
Metformin12$44$4
Atenolol16$36$2

2014: 27 drugs

Part D drugs prescribed in 2014
Truvada62$80,039$1,291
Atripla19$39,121$2,059
Prezista28$32,467$1,160
Reyataz24$28,640$1,193
Epzicom26$26,916$1,035
Isentress22$24,153$1,098
Viread22$18,566$844
Norvir52$16,973$326
Kaletra19$14,936$786
Dronabinol13$9,742$749
Abacavir17$6,567$386
Fluconazole12$1,954$163
Avodart13$1,719$132
Lovaza14$1,702$122
Oxycodone23$1,049$46
Bupropion Xl27$617$23
Dapsone13$521$40
Pravastatin13$254$20
Acyclovir13$250$19
Terazosin32$236$7
Omeprazole15$165$11
Amlodipine Besylate23$113$5
Hydrochlorothiazide25$110$4
Atorvastatin11$107$10
Pantoprazole12$95$8
Methimazole13$74$6
Atenolol12$50$4

2013: 22 drugs

Part D drugs prescribed in 2013
Truvada56$69,555$1,242
Epzicom38$37,577$989
Prezista31$33,969$1,096
Reyataz27$29,417$1,090
Isentress19$19,826$1,043
Norvir51$19,015$373
Kaletra23$17,628$766
Dronabinol15$15,978$1,065
Abacavir29$12,030$415
Viread13$10,380$798
Avodart13$1,629$125
Oxycodone16$1,197$75
Fluconazole13$1,167$90
Dapsone13$735$57
Bupropion Xl20$640$32
Terazosin31$296$10
Omeprazole15$241$16
Ketoconazole16$160$10
Methimazole13$108$8
Clonazepam16$97$6
Amlodipine Besylate16$97$6
Hydrochlorothiazide21$68$3

Professional record

NPI
1871631507
Licence
CA A87614California A87614: Current · expires 2028-04-30
More record details
Sole proprietor
Yes
Taxonomy
Internal medicine (207R00000X)
Mailing address
3200 Middlefield Rd Ste C, Palo Alto, CA, 94306
NPI first listed
2007-02-02
NPI last updated
2023-05-30
NPI record certified
2023-05-30

This is when the NPI record was last certified, not a medical board exam.